Berkow RL - Search Results

1

A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.

Weitman S, Langevin AM, Berkow RL, Thomas PJ, Hurwitz CA, Kraft AS, Dubowy RL, Smith DL, Bernstein M. Weitman S, et al. Among authors: berkow rl. Clin Cancer Res. 1999 Sep;5(9):2344-8. Clin Cancer Res. 1999. PMID: 10499603 Clinical Trial.

2

In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.

Berkow RL, Schlabach L, Dodson R, Benjamin WH Jr, Pettit GR, Rustagi P, Kraft AS. Berkow RL, et al. Cancer Res. 1993 Jun 15;53(12):2810-5. Cancer Res. 1993. PMID: 8504423

3

Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor.

Berkow RL, Kraft AS. Berkow RL, et al. Biochem Biophys Res Commun. 1985 Sep 30;131(3):1109-16. doi: 10.1016/0006-291x(85)90205-0. Biochem Biophys Res Commun. 1985. PMID: 2996535

4

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

Kraft AS, Smith JB, Berkow RL. Kraft AS, et al. Among authors: berkow rl. Proc Natl Acad Sci U S A. 1986 Mar;83(5):1334-8. doi: 10.1073/pnas.83.5.1334. Proc Natl Acad Sci U S A. 1986. PMID: 3456591 Free PMC article.

5

Tyrosine kinase and phosphotyrosine phosphatase activity in human promyelocytic leukemia cells and human polymorphonuclear leukocytes.

Kraft AS, Berkow RL. Kraft AS, et al. Among authors: berkow rl. Blood. 1987 Aug;70(2):356-62. Blood. 1987. PMID: 3038210 Free article.

6

Dissociation of human neutrophil activation events by prolonged treatment with amiloride.

Berkow RL, Dodson RW, Kraft AS. Berkow RL, et al. J Lab Clin Med. 1987 Jul;110(1):97-105. J Lab Clin Med. 1987. PMID: 3036978

7

Specific binding of phorbol esters to nuclei of human promyelocytic leukemia cells.

Kraft AS, Appling C, Berkow RL. Kraft AS, et al. Among authors: berkow rl. Biochem Biophys Res Commun. 1987 Apr 14;144(1):393-401. doi: 10.1016/s0006-291x(87)80523-5. Biochem Biophys Res Commun. 1987. PMID: 3472520

8

Human neutrophils contain distinct cytosolic and particulate tyrosine kinase activities: possible role in neutrophil activation.

Berkow RL, Dodson RW, Kraft AS. Berkow RL, et al. Biochim Biophys Acta. 1989 Aug 31;997(3):292-301. doi: 10.1016/0167-4838(89)90200-8. Biochim Biophys Acta. 1989. PMID: 2765566

9

The effect of a protein kinase C inhibitor, H-7, on human neutrophil oxidative burst and degranulation.

Berkow RL, Dodson RW, Kraft AS. Berkow RL, et al. J Leukoc Biol. 1987 May;41(5):441-6. doi: 10.1002/jlb.41.5.441. J Leukoc Biol. 1987. PMID: 3033114

10

Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.

Castleberry RP, Cantor AB, Green AA, Joshi V, Berkow RL, Buchanan GR, Leventhal B, Mahoney DH, Smith EI, Hayes FA. Castleberry RP, et al. Among authors: berkow rl. J Clin Oncol. 1994 Aug;12(8):1616-20. doi: 10.1200/JCO.1994.12.8.1616. J Clin Oncol. 1994. PMID: 8040674 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters